Life Science Leader Magazine Supplements

CRO Guide 2016

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link:

Contents of this Issue


Page 37 of 45

K E Y W W W.C R O L E A D E R S H I PA W A R D S .C O M 2016 CRO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CRO LEADERSHIP AWARDS 2016 36 CAPABILITIES COMPATIBILITY EXPERTISE QUALITY RELIABILITY CATEGORIES WON CATEGORIES WON CATEGORIES WON Chiltern Wilmington, NC +1 910 338 4760 Christine Wigert Key locations: United States, United Kingdom, Asia-Pacifc, Central and Eastern Europe, Latin America, Middle East, North Africa DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2) DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) MAIN SERVICE AREAS: Lab, Full Service Clinical MAIN SERVICE AREAS: Full Service Clinical MAIN SERVICE AREAS: Lab, Preclinical, Full Service Clinical "It is an honor to have our clients recognize us with these awards. Celerion delivers Applied Translational Medicine to help our clients generate key data very early and enable faster go/no-go decisions. With over 40 years of experience, scientifc expertise, clinical capabilities, and bioanalytical laboratories, Celerion provides global innovative solutions in support of complex studies in healthy subjects and patients. These awards reinforce our commitment to responding to our clients' challenges in drug development." "We are proud to be recognized by our peers as one of the top CROs in the industry. We are the only CRO to be awarded in fve overall categories fve years in a row. This is a testament to our commitment to building strong collaborative partnerships and striving for clinical excellence. We will continue to work hard for our clients and provide top-level performance going forward." "We pride ourselves in delivering high-quality solutions that meet our clients' needs within each phase of drug development, from preclinical testing to regulatory approval and beyond. Through the power of LabCorp, those solutions have expanded to include development of industry-leading capabilities in informatics, companion diagnostics, patient recruitment, and other technologies that will improve success, reduce the time and cost of trials, and bring new and innovative medicines to patients even sooner." SERVICES & CAPABILITIES: Celerion conducts frst-in-human, clinical proof-of-concept & dose response in patients, cardiovascular safety, & NDA-enabling clinical pharmacology studies. Sup- port is also provided in statistics, PK/PD analysis, & small/large molecule bioanalytical services. THERAPEUTIC AREAS: respiratory, metabolic disease, vaccines, renal & hepatic impairment, oncology, autoimmune disorders, cardiovascular, ophthalmology & personalized medicine SERVICES & CAPABILITIES: clinical development, clinical supplies, data & analysis, medical, regulatory & pharmacovigilance, & strategic service provision THERAPEUTIC AREAS: anti-infectives & vaccines, cardiovascular, cell therapy, central nervous system, dermatology, endocrinology, infammation, oncology, ophthalmology, orthopedics, radiology & nuclear medicine, respiratory, & women's health SERVICES & CAPABILITIES: research, lead optimization, analytical services, safety assessment, consulting, clinical development, clinical testing, commercialization, & manufacturing support THERAPEUTIC AREAS: infammation, oncology, cardiovascular/metabolic, neuroscience, infectious disease, analgesic, anti-infectives, CNS, dermatology, GI, hematology, hormonal therapy, immunology, ocular, renal disease, & respiratory disease SUSAN THORNTON President & CEO DR. JIM ESINHART CEO DEB KELLER CEO Covance Inc. Princeton, NJ +1 609 452 4440 or + 00 800 2682 2682 Jared Freedberg Key locations: Brazil, China, Germany, Russia, Singapore, Switzerland, United Kingdom, United States Celerion Lincoln, NE +1 402 476 2811 David Maya Key locations: Lincoln, NE; Phoenix, AZ; Belfast, Northern Ireland UK; Zurich, Switzerland; Montreal, Quebec, Canada; Vienna, Austria; Berlin, Germany; Seoul, South Korea INDIVIDUAL ATTRIBUTE AWARDS: data quality, offered innovative solutions, operational excellence INDIVIDUAL ATTRIBUTE AWARDS: data quality, meeting overall project timelines, operational excellence, responsiveness INDIVIDUAL ATTRIBUTE AWARDS: data quality, meeting overall project timelines, offered innovative solutions, operational excellence, responsiveness, technology for real-time access to data

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CRO Guide 2016